El Vínculo El Vínculo.
Awarded European Union SuppliesFramework agreement

FURNIZARE MEDICAMENTE PROGRAME NATIONALE

Buyer: SPITALUL JUDETEAN SATU MARE

Published
8 May 2024
Procedure
Open procedure
Notice number
00271999-2024
Reference
408c2ec2-3049-49a3-a610-16daee340410
Official source
Official source

CPV codes

Description

FURNIZARE MEDICAMENTE PROGRAME NATIONALE –Spitalul Judetean de Urgenta Satu Mare Avand in vedere introducerea unor noi molecule in terapia pacientilor cu citostatice si cresterea numarului de indicatii medicale in ceea ce priveste bolnanii de cancer, respectiv faptul ca aprovizionarea cu medicamente se face in functie de numarul de pacienti, informatii care nu se cunosc cu precizie in momentul initierii unei proceduri de achizitie medicamente, autoritatea contractanta a decis ca pentru fiecare lot in parte, procedura sa se finalizeze prin incheierea unui acord cadru cu mai multi ofertanti, numarul maxim 3,fara reluarea competitiei, pentru o perioada de 36 luni. Acordul cadru are ca obiect FURNIZARE MEDICAMENTE PROGRAME NATIONALE Autoritatea contractanta doreste sa raspunda necesitatilor identificate in cadrul spitalului, in baza referatului initial de necesitate nr.10401/11.06.2020 aprobat de conducerea unitatii,actualizat conform publicarii modificarilor CANAMED incepand cu data de 01.07.2020 prin referat nr. 12180/14.07.2020 si a referatului 13567/10.08.2020 intocmit dupa eliminarea celor trei loturi atribuite in Licitatia CN 1022802. Se va incheia un acord cadru pe o perioad…

Lots (68)

LotDescriptionCPV codeAmount
1 ATEZOLIZUMAB 33652100-6 ANTINEOPLAZICE 1200 mg/20 ml Conc.pt.sol.perf. flacon
RO115
33652100 Agentes antineoplásicos
2 CABAZITAXELUM 33652100-6 ANTINEOPLAZICE 60 mg conc+solv pt sol perf flacon
RO115
33652100 Agentes antineoplásicos
3 CARBOPLATINUM 33652100-6 ANTINEOPLAZICE 50 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
4 CISPLATINUM 33652100-6 ANTINEOPLAZICE 1mg/ml-100ml Conc. Pt. sol. Perf flacon
RO115
33652100 Agentes antineoplásicos
5 CISPLATINUM 33652100-6 ANTINEOPLAZICE 10 mg Conc. Pt. sol. Perf flacon
RO115
33652100 Agentes antineoplásicos
6 DOXORUBICINUM 33652100-6 ANTINEOPLAZICE 10 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
7 DOXORUBICINUM 33652100-6 ANTINEOPLAZICE 150 mg Conc ptr sol perf flacon
RO115
33652100 Agentes antineoplásicos
8 DOXORUBICINUM CLORHIDRAT in lipozomi PEG 33652100-6 ANTINEOPLAZICE 2mg/ml-10 ml Conc ptr sol perf flacon
RO115
33652100 Agentes antineoplásicos
9 ACIDUM PAMIDRONICUM 33652100-6 ANTINEOPLAZICE 30 mg Conc.pt.sol.perf. flacon sau fiola
RO115
33652100 Agentes antineoplásicos
10 ACIDUM ZOLENDRONICUM 33652100-6 ANTINEOPLAZICE 4 mg /5ml Conc.pt.sol.perf. flacon
RO115
33652100 Agentes antineoplásicos
11 ACIDUM ZOLENDRONICUM 33652100-6 ANTINEOPLAZICE 4 mg/100 ml sol.perf. flacon sau punga
RO115
33652100 Agentes antineoplásicos
12 AFLIBERCEPTUM 33652100-6 ANTINEOPLAZICE 200mg Conc.pt.sol.perf. flacon
RO115
33652100 Agentes antineoplásicos
13 AFLIBERCEPTUM 33652100-6 ANTINEOPLAZICE 100mg Conc.pt.sol.perf. flacon
RO115
33652100 Agentes antineoplásicos
14 AFLIBERCEPTUM 33652100-6 ANTINEOPLAZICE 40mg/ml sol inj flacon
RO115
33652100 Agentes antineoplásicos
15 ARSENICUM TRIOXIDUM 33652100-6 ANTINEOPLAZICE 1mg/ml-10 ml Conc.pt.sol.perf. fiola
RO115
33652100 Agentes antineoplásicos
16 BLEOMYCINUM SULFAS 33652100-6 ANTINEOPLAZICE 15000UI Pulb. Ptr.sol.inj flacon
RO115
33652100 Agentes antineoplásicos
17 BORTEZOMIBUM 33652100-6 ANTINEOPLAZICE 3,5mg Pulb.pt.sol inj flacon
RO115
33652100 Agentes antineoplásicos
18 BORTEZOMIBUM 33652100-6 ANTINEOPLAZICE 2,5mg Pulb.pt.sol inj flacon
RO115
33652100 Agentes antineoplásicos
19 CARBOPLATINUM 33652100-6 ANTINEOPLAZICE 150mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
20 CARBOPLATINUM 33652100-6 ANTINEOPLAZICE 450 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
21 CARBOPLATINUM 33652100-6 ANTINEOPLAZICE 600 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
22 CYCLOPHOSPHAMIDUM 33652100-6 ANTINEOPLAZICE 200 mg pulb.pt.sol.inj/perf flacon
RO115
33652100 Agentes antineoplásicos
23 DACARBAZINUM 33652100-6 ANTINEOPLAZICE 500mg pulb.pt.sol.inj. flacon
RO115
33652100 Agentes antineoplásicos
24 DACARBAZINUM 33652100-6 ANTINEOPLAZICE 200mg pulb.pt.sol.inj. flacon
RO115
33652100 Agentes antineoplásicos
25 DARATUMUMABUM 33652100-6 ANTINEOPLAZICE 20 mg/ml-5 ml Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
26 DARATUMUMABUM 33652100-6 ANTINEOPLAZICE 20 mg/ml-20 ml Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
27 DECITABINUM 33652100-6 ANTINEOPLAZICE 50 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
28 DINUTUXIMAB BETA 33652100-6 ANTINEOPLAZICE 20 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos
29 DOCETAXELUM 33652100-6 ANTINEOPLAZICE 80 mg Conc ptr sol perf flacon
RO115
33652100 Agentes antineoplásicos
30 DOCETAXELUM 33652100-6 ANTINEOPLAZICE 160 mg Conc.ptr.sol perf flacon
RO115
33652100 Agentes antineoplásicos

Award criteria

Awards

Awarded toAmountDate
ALLIANCE HEALTHCARE ROMÂNIA SRL 66,955,572 RON
MEDIPLUS EXIM 66,929,976 RON
MEDIPLUS EXIM 66,929,976 RON
MEDIPLUS EXIM 66,929,976 RON
MEDIPLUS EXIM 66,929,976 RON
MEDIPLUS EXIM 66,929,976 RON
MEDIPLUS EXIM 66,929,976 RON
PHARMAFARM 38,217,118 RON
FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. 38,194,654 RON
FARMEXIM S.A. 34,830,950 RON

Official publications

Other tenders from SPITALUL JUDETEAN SATU MARE

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is SPITALUL JUDETEAN SATU MARE (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.